Protein analysis confirmed that bindarit treatment increased PRMT7, VEGFR2 and CDH5 levels while significantly reducing p-eIF2α, CHOP and γH2AX levels compared with vehicle-treated MI hearts (Fig. 8g, h). The gene discussed is EIF2A; the disease is myocardial infarction.